Breaking News Instant updates and real-time market news.

$NSD

NASDAQ Market Internals

/

+

12:17
04/19/21
04/19
12:17
04/19/21
12:17

NASDAQ market internals summary

Volume is above average for this time of day. Breadth is mixed with issues and volume bearish while new highs to new lows are bullish (positive divergence). Advancing Issues: 878 / Declining Issues: 3256 -- for a ratio of 0.3 to 1. Advancing Volume: 795,620,000 / Declining Volume: 1,241,977,000 -- for a ratio of 0.6 to 1. New 52-Week Highs: 129 / New 52-Week Lows: 94.

TODAY'S FREE FLY STORIES

Syndicate
Federal Realty files automatic mixed securities shelf  09:20
05/07/21
05/07
09:20
05/07/21
09:20
FRT

Federal Realty

$114.03 /

+4.045 (+3.68%)

 
ShowHide Related Items >><<
FRT Federal Realty
$114.03 /

+4.045 (+3.68%)

FRT Federal Realty
$114.03 /

+4.045 (+3.68%)

05/06/21 Piper Sandler
Federal Realty upgraded to Overweight from Neutral at Piper Sandler
04/15/21 Deutsche Bank
Federal Realty price target raised to $113 from $99 at Deutsche Bank
03/22/21 Truist
Federal Realty price target raised to $96 from $88 at Truist
02/23/21 Mizuho
Federal Realty price target raised to $102 from $87 at Mizuho
FRT Federal Realty
$114.03 /

+4.045 (+3.68%)

FRT Federal Realty
$114.03 /

+4.045 (+3.68%)

Recommendations
HLS Therapeutics Covid headwinds likely to persist, says Clarus » 09:19
05/07/21
05/07
09:19
05/07/21
09:19
HLTRF

HLS Therapeutics

$15.00 /

+ (+0.00%)

Clarus analyst Noel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLTRF HLS Therapeutics
$15.00 /

+ (+0.00%)

03/24/21 Raymond James
HLS Therapeutics price target raised to C$28 from C$27 at Raymond James
01/21/21 Raymond James
HLS Therapeutics initiated with an Outperform at Raymond James
11/06/20 Canaccord
HLS Therapeutics price target raised to C$30.50 from C$29 at Canaccord
10/01/20 Clarus
HLS Therapeutics price target raised to C$33.25 from C$31 at Clarus
Recommendations
Funko price target raised to $25 from $18 at Truist » 09:19
05/07/21
05/07
09:19
05/07/21
09:19
FNKO

Funko

$21.27 /

-0.14 (-0.65%)

Truist analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FNKO Funko
$21.27 /

-0.14 (-0.65%)

FNKO Funko
$21.27 /

-0.14 (-0.65%)

07:36 Today DA Davidson
Funko upgraded to Buy from Neutral at DA Davidson
06:45 Today DA Davidson
Funko upgraded to Buy from Neutral at DA Davidson
04/19/21 JPMorgan
Funko price target raised to $25 from $20 at JPMorgan
03/24/21 Piper Sandler
Funko rallied yesterday on prior CEO interview, says Piper Sandler
FNKO Funko
$21.27 /

-0.14 (-0.65%)

FNKO Funko
$21.27 /

-0.14 (-0.65%)

FNKO Funko
$21.27 /

-0.14 (-0.65%)

FNKO Funko
$21.27 /

-0.14 (-0.65%)

Downgrade
Centerra Gold downgraded to Underperformer from Neutral at CIBC » 09:18
05/07/21
05/07
09:18
05/07/21
09:18
CGAU

Centerra Gold

$9.85 /

+0.43 (+4.56%)

CIBC analyst Anita Soni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGAU Centerra Gold
$9.85 /

+0.43 (+4.56%)

CGAU Centerra Gold
$9.85 /

+0.43 (+4.56%)

04/23/21 National Bank
Centerra Gold price target raised to C$18.50 from C$17.50 at National Bank
04/21/21 Canaccord
Centerra Gold downgraded to Speculative Buy from Buy at Canaccord
Options
Overnight activity included 1760 trades in SPX and 21 trades in VIX » 09:18
05/07/21
05/07
09:18
05/07/21
09:18
SPX

S&P 500

/

+

, VIX

Volatility Index S&P 500 Options

/

+

1760 trades were executed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
/

+

SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
VIX Volatility Index S&P 500 Options
/

+

SPX S&P 500
/

+

SPX S&P 500
/

+

SPX S&P 500
/

+

VIX Volatility Index S&P 500 Options
/

+

SPX S&P 500
/

+

Conference/Events
Scorpio Tankers participates in a conference call hosted by B. Riley » 09:16
05/07/21
05/07
09:16
05/07/21
09:16
STNG

Scorpio Tankers

$18.01 /

+0.11 (+0.61%)

B. Riley hosts conference…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STNG Scorpio Tankers
$18.01 /

+0.11 (+0.61%)

STNG Scorpio Tankers
$18.01 /

+0.11 (+0.61%)

03/29/21 H.C. Wainwright
Scorpio Tankers initiated with a Buy at H.C. Wainwright
03/19/21 BTIG
Scorpio Tankers price target raised to $28 from $25 at BTIG
02/19/21 B. Riley Securities
Scorpio Tankers price target lowered to $35 from $40 at B. Riley Securities
02/18/21 Deutsche Bank
Scorpio Tankers downgraded to Hold at Deutsche Bank on 'weak' governance
STNG Scorpio Tankers
$18.01 /

+0.11 (+0.61%)

STNG Scorpio Tankers
$18.01 /

+0.11 (+0.61%)

Recommendations
JFrog price target lowered to $86 from $95 at Needham » 09:16
05/07/21
05/07
09:16
05/07/21
09:16
FROG

JFrog

$41.98 /

-1.41 (-3.25%)

Needham analyst Jack…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FROG JFrog
$41.98 /

-1.41 (-3.25%)

FROG JFrog
$41.98 /

-1.41 (-3.25%)

07:27 Today Oppenheimer
JFrog price target lowered to $61 from $75 at Oppenheimer
04/23/21 Berenberg
JFrog initiated with a Buy at Berenberg
04/13/21 Summit Insights
JFrog upgraded to Hold from Sell at Summit Insights
01/05/21 Piper Sandler
JFrog price target lowered to $65 from $76 at Piper Sandler
FROG JFrog
$41.98 /

-1.41 (-3.25%)

  • 16
    Sep
FROG JFrog
$41.98 /

-1.41 (-3.25%)

FROG JFrog
$41.98 /

-1.41 (-3.25%)

FROG JFrog
$41.98 /

-1.41 (-3.25%)

Earnings
Farmer Bros. reports Q3 EPS (78c) vs. ($2.32) a year ago » 09:14
05/07/21
05/07
09:14
05/07/21
09:14
FARM

Farmer Bros.

$10.56 /

+0.07 (+0.67%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FARM Farmer Bros.
$10.56 /

+0.07 (+0.67%)

FARM Farmer Bros.
$10.56 /

+0.07 (+0.67%)

03/31/21 B. Riley Securities
B. Riley upgrades Farmer Bros. to Buy with recovery 'turning a corner'
03/31/21 B. Riley Securities
Farmer Bros. upgraded to Buy from Neutral at B. Riley Securities
02/08/21 Roth Capital
Farmer Bros. price target raised to $7 from $6 at Roth Capital
01/08/21 B. Riley Securities
Farmer Bros. price target raised to $4.50 from $4 at B. Riley Securities
FARM Farmer Bros.
$10.56 /

+0.07 (+0.67%)

FARM Farmer Bros.
$10.56 /

+0.07 (+0.67%)

FARM Farmer Bros.
$10.56 /

+0.07 (+0.67%)

Recommendations
Builders FirstSource price target raised to $67 from $57 at BTIG » 09:14
05/07/21
05/07
09:14
05/07/21
09:14
BLDR

Builders FirstSource

$51.96 /

+2.92 (+5.95%)

BTIG analyst Ryan Gilbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLDR Builders FirstSource
$51.96 /

+2.92 (+5.95%)

BLDR Builders FirstSource
$51.96 /

+2.92 (+5.95%)

08:52 Today Truist
Builders FirstSource price target raised to $60 from $52 at Truist
08:50 Today B. Riley
Builders FirstSource price target raised to $62 from $56 at B. Riley
06:53 Today Barclays
Builders FirstSource price target raised to $68 from $57 at Barclays
05/06/21 RBC Capital
Builders FirstSource price target raised to $68 from $62 at RBC Capital
BLDR Builders FirstSource
$51.96 /

+2.92 (+5.95%)

BLDR Builders FirstSource
$51.96 /

+2.92 (+5.95%)

Conference/Events
UBS hardlines/broadlines analyst to hold an analyst/industry conference call » 09:14
05/07/21
05/07
09:14
05/07/21
09:14

Hardline & Broadlines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
TripAdvisor sees Q2 revenue higher than Q1, consensus $190.86M » 09:12
05/07/21
05/07
09:12
05/07/21
09:12
TRIP

TripAdvisor

$44.78 /

-0.71 (-1.56%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$44.78 /

-0.71 (-1.56%)

TRIP TripAdvisor
$44.78 /

-0.71 (-1.56%)

04/13/21 Jefferies
TripAdvisor price target raised to $29 from $24 at Jefferies
04/05/21 Evercore ISI
TripAdvisor assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
TripAdvisor initiated with a Peer Perform at Wolfe Research
03/12/21 Truist
TripAdvisor price target raised to $62 from $48 at Truist
TRIP TripAdvisor
$44.78 /

-0.71 (-1.56%)

TRIP TripAdvisor
$44.78 /

-0.71 (-1.56%)

TRIP TripAdvisor
$44.78 /

-0.71 (-1.56%)

Hot Stocks
Centene names Drew Asher as CFO, succeeding Jeffrey Schwaneke » 09:12
05/07/21
05/07
09:12
05/07/21
09:12
CNC

Centene

$65.22 /

-0.06 (-0.09%)

Centene announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNC Centene
$65.22 /

-0.06 (-0.09%)

CNC Centene
$65.22 /

-0.06 (-0.09%)

04/28/21 Morgan Stanley
Centene didn't meet 'high bar' set by peers, says Morgan Stanley
04/28/21 BMO Capital
Centene price target lowered to $77 from $88 at BMO Capital
04/19/21 Piper Sandler
Evolent Health should be bought into earnings, says Piper Sandler
03/09/21 Mizuho
Centene initiated with a Neutral at Mizuho
CNC Centene
$65.22 /

-0.06 (-0.09%)

CNC Centene
$65.22 /

-0.06 (-0.09%)

CNC Centene
$65.22 /

-0.06 (-0.09%)

CNC Centene
$65.22 /

-0.06 (-0.09%)

Recommendations
OrthoPediatrics price target raised to $72 from $64 at Truist » 09:11
05/07/21
05/07
09:11
05/07/21
09:11
KIDS

OrthoPediatrics

$61.59 /

+5.4 (+9.61%)

Truist analyst Kaila Krum…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

06:17 Today JMP Securities
OrthoPediatrics price target raised to $70 from $55 at JMP Securities
05/06/21 Piper Sandler
OrthoPediatrics price target raised to $70 from $62 at Piper Sandler
04/19/21 Truist
OrthoPediatrics price target raised to $64 from $54 at Truist
04/06/21 Piper Sandler
OrthoPediatrics price target raised to $62 from $55 at Piper Sandler
KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

  • 18
    Jun
KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

Conference/Events
UBS consumer goods analysts to hold an analyst/industry conference call » 09:10
05/07/21
05/07
09:10
05/07/21
09:10

Consumer Specialist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Auris Medical says Altamira met with FDA for pre-submission meeting for Bentrio » 09:09
05/07/21
05/07
09:09
05/07/21
09:09
EARS

Auris Medical

$2.87 /

-0.04 (-1.37%)

Auris Medical Holding and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EARS Auris Medical
$2.87 /

-0.04 (-1.37%)

EARS Auris Medical
$2.87 /

-0.04 (-1.37%)

EARS Auris Medical
$2.87 /

-0.04 (-1.37%)

EARS Auris Medical
$2.87 /

-0.04 (-1.37%)

EARS Auris Medical
$2.87 /

-0.04 (-1.37%)

Recommendations
Monster Beverage price target raised to $115 from $105 at Truist » 09:09
05/07/21
05/07
09:09
05/07/21
09:09
MNST

Monster Beverage

$95.02 /

+0.6 (+0.64%)

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNST Monster Beverage
$95.02 /

+0.6 (+0.64%)

MNST Monster Beverage
$95.02 /

+0.6 (+0.64%)

07:31 Today Deutsche Bank
Monster Beverage price target lowered to $105 from $109 at Deutsche Bank
04/29/21 Deutsche Bank
Monster Beverage price target raised to $109 from $105 at Deutsche Bank
04/12/21 Evercore ISI
Evercore ISI starts 'blue chip' Duckhorn at Outperform with $22 price target
03/17/21 Goldman Sachs
Goldman sees three attractive buys in Americas Beverages after selloff
MNST Monster Beverage
$95.02 /

+0.6 (+0.64%)

MNST Monster Beverage
$95.02 /

+0.6 (+0.64%)

MNST Monster Beverage
$95.02 /

+0.6 (+0.64%)

Hot Stocks
Groupon: Local billings in NA are tracking at 71% of 2019 levels » 09:08
05/07/21
05/07
09:08
05/07/21
09:08
GRPN

Groupon

$48.84 /

-1.9 (-3.74%)

International Local…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRPN Groupon
$48.84 /

-1.9 (-3.74%)

GRPN Groupon
$48.84 /

-1.9 (-3.74%)

03/03/21 Wedbush
Groupon price target raised to $62 from $29 at Wedbush
03/01/21 JPMorgan
JPMorgan upgrades Groupon to Neutral on new marketplace strategy
03/01/21 JPMorgan
Groupon upgraded to Neutral from Underweight at JPMorgan
01/04/21 Barclays
Groupon assumed with an Underweight at Barclays
GRPN Groupon
$48.84 /

-1.9 (-3.74%)

GRPN Groupon
$48.84 /

-1.9 (-3.74%)

GRPN Groupon
$48.84 /

-1.9 (-3.74%)

Hot Stocks
Firsthand Technology Value stockholders urged to vote to terminate agreements » 09:06
05/07/21
05/07
09:06
05/07/21
09:06
SVVC

Firsthand Technology Value Fund

$6.60 /

-0.05 (-0.75%)

Rawleigh Ralls, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Groupon on track to realize $225M of run rate savings from restructuring actions » 09:06
05/07/21
05/07
09:06
05/07/21
09:06
GRPN

Groupon

$48.84 /

-1.9 (-3.74%)

Comments taken from Q1…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRPN Groupon
$48.84 /

-1.9 (-3.74%)

GRPN Groupon
$48.84 /

-1.9 (-3.74%)

03/03/21 Wedbush
Groupon price target raised to $62 from $29 at Wedbush
03/01/21 JPMorgan
JPMorgan upgrades Groupon to Neutral on new marketplace strategy
03/01/21 JPMorgan
Groupon upgraded to Neutral from Underweight at JPMorgan
01/04/21 Barclays
Groupon assumed with an Underweight at Barclays
GRPN Groupon
$48.84 /

-1.9 (-3.74%)

GRPN Groupon
$48.84 /

-1.9 (-3.74%)

GRPN Groupon
$48.84 /

-1.9 (-3.74%)

Recommendations
Sturm Ruger price target raised to $100 from $94 at Lake Street » 09:05
05/07/21
05/07
09:05
05/07/21
09:05
RGR

Sturm Ruger

$69.48 /

+2.125 (+3.15%)

Lake Street analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RGR Sturm Ruger
$69.48 /

+2.125 (+3.15%)

RGR Sturm Ruger
$69.48 /

+2.125 (+3.15%)

10/05/20 B. Riley Securities
Firearm demand has seen meaningful uptick, says B. Riley Securities
09/24/20
Fly Intel: Top five analyst initiations
09/24/20 Aegis
Sturm, Ruger initiated with a Hold at Aegis
09/24/20 Aegis
Sturm, Ruger initiated with a Hold at Aegis
RGR Sturm Ruger
$69.48 /

+2.125 (+3.15%)

RGR Sturm Ruger
$69.48 /

+2.125 (+3.15%)

Hot Stocks
Medicenna Therapeutics announces publication of phase 2b trial data on MDNA55 » 09:05
05/07/21
05/07
09:05
05/07/21
09:05
MDNA

Medicenna Therapeutics

$3.49 /

+0.23 (+7.06%)

Medicenna Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDNA Medicenna Therapeutics
$3.49 /

+0.23 (+7.06%)

MDNA Medicenna Therapeutics
$3.49 /

+0.23 (+7.06%)

12/17/20 Oppenheimer
Medicenna Therapeutics initiated with an Outperform at Oppenheimer
09/10/20 H.C. Wainwright
Medicenna Therapeutics initiated with a Buy at H.C. Wainwright
MDNA Medicenna Therapeutics
$3.49 /

+0.23 (+7.06%)

General news
FX Action: USD-CAD » 09:05
05/07/21
05/07
09:05
05/07/21
09:05
$ECON

Economic Data

/

+

FX Action: USD-CAD fell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Earnings
    CoreLogic reports Q1 adjusted EPS $1.20, consensus $1.10 » 09:04
    05/07/21
    05/07
    09:04
    05/07/21
    09:04
    CLGX

    CoreLogic

    $79.61 /

    -0.07 (-0.09%)

    Reports Q1 revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CLGX CoreLogic
    $79.61 /

    -0.07 (-0.09%)

    CLGX CoreLogic
    $79.61 /

    -0.07 (-0.09%)

    03/05/21 Keefe Bruyette
    CoStar decision to walk removes overhang on shares, says Keefe Bruyette
    02/04/21 Stephens
    CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens
    01/06/21 Wolfe Research
    CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research
    12/01/20 Truist
    CoreLogic downgraded to Hold from Buy at Truist
    CLGX CoreLogic
    $79.61 /

    -0.07 (-0.09%)

    CLGX CoreLogic
    $79.61 /

    -0.07 (-0.09%)

    CLGX CoreLogic
    $79.61 /

    -0.07 (-0.09%)

    Hot Stocks
    Borqs Technologies completes $23M private placement » 09:03
    05/07/21
    05/07
    09:03
    05/07/21
    09:03
    BRQS

    Borqs Technologies

    /

    +

    Borqs Technologies…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BRQS Borqs Technologies
    /

    +

    Hot Stocks
    General Cannabis CEO Steve Gutterman steps down, Adam Hershey named interim CEO » 09:02
    05/07/21
    05/07
    09:02
    05/07/21
    09:02
    CANN

    General Cannabis

    /

    +

    General Cannabis…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CANN General Cannabis
    /

    +

    CANN General Cannabis
    /

    +

    03/29/21 Stifel
    Stifel says New York adult use cannabis market represents $5B opportunity
    02/02/21 Craig-Hallum
    Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
    01/29/21 Stifel
    'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
    12/04/20 Alliance Global Partners
    Alliance Global sees low odds of MORE Act passing this congressional session
    CANN General Cannabis
    /

    +

    CANN General Cannabis
    /

    +

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.